Skip to main content
Log in

Is the QRS duration useful for determining the optimal timing of pulmonary valve replacement after tetralogy of Fallot repair?

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

In pulmonary valve replacement (PVR) after tetralogy of Fallot (TOF) repair, the right ventricular end-diastolic and end-systolic volume index (RVEDVI and RVESVI) of cardiac magnetic resonance imaging (cMRI) are often used as indicators of the RV volume. We examined the utility of QRS duration, cardiothoracic ratio (CTR), and plasma brain natriuretic peptide (BNP) as indicators of the appropriate timing of cMRI to assess the RV volume and function before PVR.

Methods

We assessed the correlation of QRS duration, CTR, and BNP with RVEDVI and RVESVI on cMRI in 26 patients after TOF repair. Fifteen underwent PVR (age, 45.2 ± 11.4 years). Twelve underwent post-PVR cMRI. The RV volume change from before to after PVR was investigated.

Results

QRS duration, BNP, and CTR were positively correlated with RVEDVI and RVESVI after TOF repair. The post-PVR QRS duration was also positively correlated with post-PVR RVEDVI (p = 0.017) and RVESVI (p = 0.001). From before to after PVR, in 5 cases with QRS duration ≤ 160 ms, the QRS duration decreased from 110.4 ± 28.9 to 101.8 ± 30.5 ms (p = 0.063). Both RVEDVI and RVESVI decreased to the normal range in 4 of 5 cases. In contrast, in 7 cases with QRS duration > 160 ms, the QRS duration decreased from 183.0 ± 17.4 to 160.3 ± 23.8 ms (p = 0.013); however, RVESVI did not normalize in 6 of 7 cases.

Conclusions

A prolonged QRS duration is a useful marker of RVEDVI and RVESVI enlargement after TOF repair. We recommend performing cMRI before the QRS duration reaches 160 ms due to normalization of the RV volume after PVR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Dehaki MG, Al-Dairy A, Rezaei Y, Omrani G, Jalali AH, Javadikasgari H, et al. Mid-term outcomes of mechanical pulmonary valve replacement: a single-institutional experience of 396 patients. Gen Thorac Cardiovasc Surg. 2019;67:289–96.

    Article  PubMed  Google Scholar 

  2. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Pediatr Card Surg Annu. 2006;9:11–22.

    Google Scholar 

  3. Helbing WA, Niezen RA, Cessie SLE, Van Der Geest RJ, Ottenkamp J, De Roos A. Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol. 1997;28:1827–35.

    Article  Google Scholar 

  4. Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JCC, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002;40:2044–52.

    Article  PubMed  Google Scholar 

  5. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–82.

    Article  PubMed  Google Scholar 

  6. Bokma JP, Winter MM, Oosterhof T, Vliegen HW, Van Dijk AP, Hazekamp MG, et al. Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Eur Heart J. 2016;37:829–35.

    Article  PubMed  Google Scholar 

  7. Lee C, Kim YM, Lee CH, Kwak JG, Park CS, Song JY, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol. 2012;60:1005–14.

    Article  PubMed  Google Scholar 

  8. Oosterhof T, Van Straten A, Vliegen HW, Meijboom FJ, Van Dijk APJ, Spijkerboer AM, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007;116:545–51.

    Article  PubMed  Google Scholar 

  9. Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010;122:S201–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Guidelines for Management of Congenital Heart Diseases in Adults (JCS 2017). 2017;88–93.

  11. Kurotobi S, Taniguchi K, Sano T, Naito H, Matsushita T, Kogaki S, et al. Determination of timing for reoperation in patients after right ventricular outflow reconstruction. Am J Cardiol. 2005;95:1344–50.

    Article  PubMed  Google Scholar 

  12. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–13.

    Article  CAS  PubMed  Google Scholar 

  13. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004;43:1068–74.

    Article  PubMed  Google Scholar 

  14. Abd El Rahman MY, Abdul-Khaliq H, Vogel M, Alexi-Meskishvili V, Gutberlet M, Lange PE. Relation between right ventricular enlargement, QRS duration, and right ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation after surgical repair. Heart. 2000;84:416–20.

    Article  CAS  PubMed  Google Scholar 

  15. Doughan AR, McConnell ME, Lyle TA, Book WM. Effects of pulmonary valve replacement on qrs duration and right ventricular cavity size late after repair of right ventricular outflow tract obstruction. Am J Cardiol. 2005;95:1511–4.

    Article  PubMed  Google Scholar 

  16. Cheung EWY, Lam WWM, Chiu CSW, Chau AKT, Cheung SCW, Cheung Y-F. Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot. Int J Cardiol. 2007;121:155–62.

    Article  PubMed  Google Scholar 

  17. Oosterhof T, Tulevski II, Vliegen HW, Spijkerboer AM, Mulder BJM. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol. 2006;97:1051–5.

    Article  CAS  PubMed  Google Scholar 

  18. Eindhoven JA, Menting ME, Van Den Bosch AE, Cuypers JAAE, Ruys TPE, Witsenburg M, et al. Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot. Int J Cardiol. 2014;174:550–6.

    Article  PubMed  Google Scholar 

  19. Van Huysduynen BH, Van Straten A, Swenne CA, Maan AC, Van Eck HJR, Schalij MJ, et al. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur Heart J. 2005;26:928–32.

    Article  PubMed  Google Scholar 

  20. Cocomello L, Sinha S, Gonzalez Corcia MC, Baquedano M, Benedetto U, Caputo M. Determinants of QRS duration in patients with tetralogy of Fallot after pulmonary valve replacement. J Card Surg. 2021;36:1958–68.

    Article  PubMed  Google Scholar 

  21. Scherptong RWC, Hazekamp MG, Mulder BJM, Wijers O, Swenne CA, Van Der Wall EE, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol. 2010;56:1486–92.

    Article  PubMed  Google Scholar 

  22. Romeo JLR, Takkenberg JJM, Cuypers JAAE, de Groot NMS, van de Woestijne P, Bruining N, et al. Timing of pulmonary valve replacement in patients with corrected Fallot to prevent QRS prolongation. Eur J Cardio-thoracic Surg. 2020;58:559–66.

    Article  Google Scholar 

  23. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13:1–24.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Junya Sugiura.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugiura, J., Uchita, S., Kojima, A. et al. Is the QRS duration useful for determining the optimal timing of pulmonary valve replacement after tetralogy of Fallot repair?. Gen Thorac Cardiovasc Surg 71, 437–446 (2023). https://doi.org/10.1007/s11748-022-01898-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-022-01898-0

Keywords

Navigation